Sintilimab (anti-PD-1)
CAS: 2072873-06-2
Ref. TM-T35394
| 1mg | 158.00 € | ||
| 5mg | 398.00 € | ||
| 10mg | 685.00 € | ||
| 25mg | 1,012.00 € | ||
| 50mg | To inquire |
Product Information
- IBI308, Sintilimab (anti-PD-1)
Sintilimab (IBI308) is a humanized IgG4 monoclonal antibody with significant anti-tumor activity that restores endogenous anti-tumor T-cell responses by binding to PD-1 and thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2).Sintilimab is used in combination with other compounds for the treatment of classical Hodgkin's lymphoma, non-cellular lung cancer and esophageal cancer. Sintilimab is used in combination with other compounds to treat classical Hodgkin's lymphoma, non-small cell lung cancer and esophageal cancer.
Chemical properties
Technical inquiry about: TM-T35394 Sintilimab (anti-PD-1)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
